Manipulation of NK cytotoxicity by the IAP family member Livin
about
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.IAP-targeted therapies for cancer.Expression of multiple granzymes by cytotoxic T lymphocyte implies that they activate diverse apoptotic pathways in target cells.The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin.
P2860
Manipulation of NK cytotoxicity by the IAP family member Livin
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Manipulation of NK cytotoxicity by the IAP family member Livin
@ast
Manipulation of NK cytotoxicity by the IAP family member Livin
@en
Manipulation of NK cytotoxicity by the IAP family member Livin
@en-gb
Manipulation of NK cytotoxicity by the IAP family member Livin
@nl
type
label
Manipulation of NK cytotoxicity by the IAP family member Livin
@ast
Manipulation of NK cytotoxicity by the IAP family member Livin
@en
Manipulation of NK cytotoxicity by the IAP family member Livin
@en-gb
Manipulation of NK cytotoxicity by the IAP family member Livin
@nl
prefLabel
Manipulation of NK cytotoxicity by the IAP family member Livin
@ast
Manipulation of NK cytotoxicity by the IAP family member Livin
@en
Manipulation of NK cytotoxicity by the IAP family member Livin
@en-gb
Manipulation of NK cytotoxicity by the IAP family member Livin
@nl
P2093
P921
P356
P1476
Manipulation of NK cytotoxicity by the IAP family member Livin
@en
P2093
Dina Ben-Yehuda
Gal Markel
Itay Lazar
Meital Elmalech
Ofer Mandelboim
Sa'ar Mizrahi
Yaqoub Ashhab
P2860
P304
P356
10.1002/EJI.200636600
P407
P577
2007-12-01T00:00:00Z